(Q36586913)

15 August 2017

1 reference

title

Orlistat: a review of its use in the management of obesity (English)

1 reference

15 August 2017

0 references

2

Caroline M Perry

1 reference

15 August 2017

Sheridan Henness

1

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

66

1 reference

15 August 2017

12

1 reference

15 August 2017

1625-1656

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666120-00012

15 August 2017

0 references

cites work

Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

The Effect of Short-Term (21-Day) Orlistat Treatment on the Physiologic Balance of Six Selected Macrominerals and Microminerals in Obese Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

Pharmacokinetic evaluation of the possible interaction between selected concomitant medications and orlistat at steady state in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

The influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666120-00012

Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents

21 January 2018

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

12 December 2020

The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

1 reference

12 December 2020

The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers

1 reference

12 December 2020

Effects of orlistat on obesity-related diseases - a six-month randomized trial

1 reference

12 December 2020

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns

1 reference

12 December 2020

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients

1 reference

12 December 2020

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin

1 reference

12 December 2020

Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions

1 reference

12 December 2020

The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach

1 reference

12 December 2020

Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting

1 reference

12 December 2020

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial

1 reference

12 December 2020

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

1 reference

12 December 2020

The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers

1 reference

12 December 2020

Effect of orlistat on cardiovascular disease risk in obese adults

1 reference

12 December 2020

Weight change and blood coagulability and fibrinolysis in healthy obese women

1 reference

12 December 2020

Orlistat in the long-term treatment of obesity in primary care settings

1 reference

12 December 2020

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial

1 reference

12 December 2020

Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients

1 reference

12 December 2020

A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

1 reference

12 December 2020

Effect of Orlistat in obese patients with heart failure: a pilot study.

1 reference

12 December 2020

Reduction of body weight and co-morbidities by orlistat: The XXL--Primary Health Care Trial

1 reference

12 December 2020

Diabesity: are weight loss medications effective?

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Orlistat for obesity: benefits beyond weight loss

1 reference

12 December 2020

Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels

1 reference

12 December 2020

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

1 reference

12 December 2020

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

1 reference

12 December 2020

Orlistat: in the prevention and treatment of type 2 diabetes mellitus

1 reference

12 December 2020

The burden of chronic hyperglycemia

1 reference

12 December 2020

The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study

1 reference

12 December 2020

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

12 December 2020

Orlistat: a review of its use in the management of obesity

1 reference

12 December 2020

Analysis of the XENDOS study (Xenical in the Prevention of Diabetes in Obese Subjects).

1 reference

12 December 2020

Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Orlistat: a review of its use in the management of patients with obesity

1 reference

12 December 2020

Influence of weight loss on myocardial performance index.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

1 reference

12 December 2020

Orlistat for the treatment of obesity: cost utility model

1 reference

12 December 2020

The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers

1 reference

12 December 2020

Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.

1 reference

12 December 2020

Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients: UK Multimorbidity Study.

1 reference

12 December 2020

Reduction in blood cyclosporine concentration by orlistat in two renal transplant patients

1 reference

12 December 2020

The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers

1 reference

12 December 2020

Effect of orlistat in obese patients with binge eating disorder

1 reference

12 December 2020

Human leptin: from an adipocyte hormone to an endocrine mediator

1 reference

12 December 2020

The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss

1 reference

12 December 2020

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

1 reference

12 December 2020

Effects of orlistat on fat-soluble vitamins in obese adolescents

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

1 reference

12 December 2020

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

1 reference

12 December 2020

Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers

1 reference

12 December 2020

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes

1 reference

12 December 2020

Cholesterol lowering effect of dietary weight loss and orlistat treatment--efficacy and limitations

1 reference

12 December 2020

Effect of orlistat on plasma leptin levels and risk factors for the metabolic syndrome

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

12 December 2020

Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

1 reference

12 December 2020

Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland

1 reference

12 December 2020

Lack of interaction between orlistat and oral contraceptives

1 reference

12 December 2020

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Obesity in transplant patients: case report showing interference of orlistat with absorption of cyclosporine and review of literature

1 reference

12 December 2020

The effect of orlistat-induced weight loss on interleukin-6 and C-reactive protein levels in obese subjects

1 reference

12 December 2020

Addition of orlistat to conventional treatment in adolescents with severe obesity

1 reference

12 December 2020

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia

1 reference

12 December 2020

Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers

1 reference

12 December 2020

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

1 reference

12 December 2020

Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension

1 reference

12 December 2020

Pharmacotherapy for obesity

1 reference

12 December 2020

Safety of drug therapies used for weight loss and treatment of obesity

1 reference

12 December 2020

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

1 reference

12 December 2020

Orlistat inhibits dietary cholesterol absorption

1 reference

12 December 2020

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study

1 reference

12 December 2020

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

12 December 2020

Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity

1 reference

12 December 2020

Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat

1 reference

12 December 2020

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

1 reference

12 December 2020

Orlistat for the treatment of obesity: rapid review and cost-effectiveness model

1 reference

12 December 2020

Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers

1 reference

12 December 2020

Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland

1 reference

12 December 2020

The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers

1 reference

12 December 2020

Effects of a weight-reduction program with orlistat on serum leptin levels in obese women: A 12-week, randomized, placebo-controlled study

1 reference

12 December 2020

10.2165/00003495-200666120-00012

Identifiers

DOI

1 reference

PubMed ID

16956313

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

16956313